Value of 12 Lead Electrocardiogram and Derived Methodologies in the Diagnosis of Brugada Disease

The Brugada Syndrome: From Bench to Bedside

Volumn , Issue , 2007, Pages 87-110

  Peréz Riera, Andrés Ricardo ^a   Ferreira, Celso ^b   Schapachnik, Edgardo ^c  

^a FACULDADE DE MEDICINA DO ABC   (Brazil)

^b Nursing School at ABC Foundation   (Brazil)

^c HOSPITAL GENERAL DE AGUDOS DR COSME ARGERICH   (Argentina)

Author keywords

12 lead electrocardiogram; Brugada syndrome diagnosis; Electrocardiogram (ECG); T wave; Vectorcardiogram (VCG)

Indexed keywords

EID: 84889446801     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470994900.ch7     Document Type: Chapter

References (108)

1. Alings M,Wilde A.'Brugada'syndrome: Clinical data and suggested pathophysiologic mechanism. Circulation 1999; 99:666-673.
2. Farre J. The Brugada syndrome: do we need more than the 12-lead ECG. Eur. Heart J. 2000;21:264-265.
3. Sangwatanaroj S, Prechawat S, Sunsaneewitayakul B, Sitthisook S, Tosukhowong P, Tungsanga K. Right ventricular electrocardiographic leads for detection of Brugada syndrome in sudden unexplained death syndrome survivors and their relatives. Clin. Cardiol. 2001;24:776-781.
4. Sangwatanaroj S, Prechawat S, Sunsaneewitayakul B et al. New electrocardiographic leads and the procainamide test for the detection ofthe Brugada sign in sudden unexplained death syndrome survivors and their relatives. Eur. Heart J. 2001; 22:2290-2296.
5. Nagatomo T, Abe H, Oginosawa Y et al. Reproduction of typical electrocardiographic findings of the Brugada syndrome using modified precordial leads. J UOEH 2002; 24: 383-389.
6. Nagase S, Kusano KF, Morita H et al. Epicardial electrogram of the right ventricular outflow tract in patients with the Brugada syndrome. Using the epicardial lead. J. Am. Coll. Cardiol. 2002;39:1992-1995.
7. Takagi M, Toda I, Takeuchi K et al. Utility of right precordial leads at higher intercostal space positions to diagnose Brugada syndrome. Pacing Clin. Electrophysiol. 2002;25:241-242.
8. Cabezon Ruiz S, Errazquin Saenz De Tejada F, Pedrote Martinez A et al. Normal conventional electrocardiogram with negative pharmacological stress test does not rule out Brugada syndrome. Rev. Esp. Cardiol. 2003;56:107-110.
9. Pérez Riera AR, Fortunato de Cano S, Cano MN, Schapachnik E. Significance of electrocardiogram in the Brugada Syndrome and in other arrthmogenic entities. Guidelines for prevention of sudden death. Virtual Symposium about the Brugada syndrome: ten years ofhistory: 1992/2002) www.simposio-brugada.com.ar
10. Ikeda T, Sakata T, Sakabe K et al. Noninvasive risk stratification markers in the Brugada syndrome: comparison of late potentials, T-wave alternans and QT dispersion. Pacing Clin. Electrophysiol. 2000; 23:731.
11. Ikeda T, Sakurada H. and Sakabe K et al. Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification. J. Am. Coll. Cardiol. 2001,37:1628-1634.
12. Battur MK, Aloseyed S, Oto A et al. Circadian variations of QTc dispersion: is it a clue to morning increase in sudden cardiac death. Clin. Cardiol. 1999;22:103-106.
13. Chinushi M, Washizuka T, Okumura H, Aizawa Y. Intravenous administration of class I antiarrhytmic drugs induced T wave alternans in a patient with Brugada syndrome. J. Cardiovasc. Electrophysiol. 2001;12:493-495.
14. Ruskin JN. Role of invasive electrophysiology testing in the evaluation and treatment of patients at high risk of sudden cardiac death. Circulation 1992; 85 (suppl I): 1152-1159.
15. Tada H, Nogami A, Shimizu W et al. ST segment and T wave alternans in a patient with Brugada syndrome. Pacing Clin. Electrophysiol. 2000; 23:413-415.
16. Takagi M, Doi A, Takeuchi K, Yoshikawa J. Pilsicanide-induced marked T wave alternans and ventricular fibrillation in a patient with Brugada syndrome. J. Cardiovasc. Electrophysiol. 2002; 13:837.
17. Chinushi Y, Chinushi M, Toida T, Aizawa Y. Class I antiar-rhythmic drug and coronary vasospasm-induced T wave alternans and ventricular tachyarrhythmia in a patient with Brugada syndrome and vasospastic angina. J. Cardiovasc. Electrophysiol. 2002; 13:191-194.
18. Morita H, Nagase S, Kusano K, Ohe T. Spontaneous T wave alternans and premature ventricular contractions during febrile illness in a patient with Brugada syndrome. J. Cardiovasc. Electrophysiol. 2002;13:816-818.
19. Maia IG, Soares MW, Boghossian SH, Sa R. The Brugada syndrome. Outcome of one case. Arq. Bras. Cardiol. 2000;74:437-445.
20. Krittayaphong R, Veerakul G, Nademanee K, Kangkagate C. Heart rate variability in patients with Brugada syndrome in Thailand. Eur. Heart J. 2003; 24:1771-1778.
21. Shimizu W, Matsuo K and Takagi M et al. Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication ofeighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms. J. Cardiovasc. Electrophysiol. 2000; 11:396-404.
22. Pérez Riera AR, Fortunato de Cano S, Fleury de Padua Neto LA, Schapachnik E. Síndrome de Brugada: Nuevos conceptos y expectativas futuras. Rev. Argent. Cardiol. 2001; 69:652-662.
23. Pérez Riera AR, Schapachnik E, Ferreira C. Brugada disease: chronology of discovery and paternity. Preliminary observations and historical aspects. Indian Pacing Electrophysiol J. 2003;3:244.
24. Wilde AA,Antzelevitch C, Borggrefe M et al. Proposed diagnostic criteria for the Brugada syndrom. Eur. Heart J. 2002;23:1648-1654.
25. Balser JR. Sodium 'channelopathies' and sudden death: Must you be so sensitive. Circ. Res. 1999;85:872-874.
26. Kirsch GE. Ion channel defects in primary electrical diseases of the heart. In F. Lehmann-Horn, ed.,. Channelopathies. 2000; 115-151.Elsevier Science.
27. Celesia GG. Disorders of membrane channels or channelopathies. Clin. Neurophysiol. 2001; 112:2-18.
28. Marbán E. Cardiac channelopathies. Virtual Symposium about the Brugada syndrome: ten years of history: 1992/2002) www.simposio-brugada.com.ar
29. Cau C. The Brugada syndrome.A predicted sudden juvenile death. Minerva Med. 1999;90:359-364.
30. Tan HL, Bezzina CR, Smits JP,Verkerk AO, Wilde AA. Genetic control of sodium channel function. Cardiovasc. Res. 2003; 57:961-973.
31. Hari P, Chemiti GK, Joshi A. Brugada syndrome also linked to sudden cardiac death. Postgrad. Med. 2001;109:18.
32. Futterman LG, Lemberg L. Brugada. Am. J. Crit. Care 2001; 10:360-364.
33. Matsuo K, Kurita T, Inagaki M et al. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. Eur. Heart J. 1999;20:465-470.
34. Di Diego JM, Cordeiro JM, Goodrow RJ et al. Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. Circulation 2002;106:2004-2011.
35. Antzelevitch C. Androgens and male predominance of the Brugada syndrome phenotype. Pacing Clin. Electrophysiol. 2003; 26:1429-1431.
36. Matsuo K, Akahoshi M, Seto S, Yano K. Disappearance of the Brugada-type electrocardiogram after surgical castration. Pacing Clin. Electrophysiol. 2003;26:1551-1553.
37. Antzelevitch C, Brugada P, Brugada J et al. Brugada syndrome a decade of progres. Circ. Res. 2002;91:1114-1118.
38. Remme CA, Wever EF, Wilde AA et al. Diagnosis and long-term follow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation. Eur. Heart J. 2001;22:400-409.
39. Nademanee K, Veerakul G, Nimmannit S et al. Arrhyth-mogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997;96:2595-2600.
40. Nademanee K. Sudden unexplained death syndrome in Southeast Asia. Am.J. Cardiol. 1997; 79:10-11.
41. MacKenzie R. The Brugada syndrome-an electrocardiogram with important mortality implications. J. Insur. Med. 2001; 33:106-109.
42. Takenaka S, Kusano KF, Hisamatsu K et al. Relatively benign clinical course in asymptomatic patients with Brugada-type electrocardiogram without family history of sudden death. J. Cardiovasc. Electrophysiol. 2001; 12:2-6.
43. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J.Am. Coll. Cardiol. 1992; 20:1391-1396.
44. Villacorta H, Faig Torres RA, Simões de Castro IR, Lambert H. de Araujo Gonzáles, Alonso R. Morte súbita em paciente com bloqueio de ramo direito e elevação persistente do segmento ST. Arq. Bras. Cardiol. 1996;66:229-231.
45. Itoh H, Shimizu M, Ino H, Okeie K, Yamaguchi M, Fujino N, Mabuchi H. Hokuriku Brugada Study Group. Arrhythmias in patients with Brugada-type electrocardiograph findings. Jpn. Circ. J. 2001; 65:483-486.
46. Eckardt L, Kirchhof P, Loh P et al. Brugada syndrome and supraventricular tachyarrhythmias: a novel association. J. Cardiovasc. Electrophysiol. 2001;12:680-685.
47. Eckardt L, Kirchhof P,Johna R, Haverkamp W, Breithardt G, Borggrefe M. Wolff-Parkinson-White syndrome associated with Brugada syndrome. Pacing Clin. Electrophysiol. 2001; 24:1423-1424.
48. Smits JP, Eckardt L, Probst V et al. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J. Am. Coll. Cardiol. 2002;40:350-356.
49. Kobayashi T, Shintani U, Yamamoto T et al. Familial occurrence of electrocardiographic abnormalities of the Brugada-type. Intern. Med. 1996;35:637-640.
50. Atarashi H, Ogawa S, Harumi K et al. Idiopathic ventricular fibrillation investigators. Three-year follow-up of patients with right bundle branch block and ST segment elevation in the right precordial leads: Japanese Registry of Brugada Syndrome. Idiopathic Ventricular Fibrillation Investigators. J. Am. Coll. Cardiol. 2001;37:1916-1920.
51. Bianco M, Bria S, Gianfelici A, et al. Does early repolarization in the athlete have analogies with the Brugada syndrome. Eur. Heart J. 2001;22:504-510.
52. Gussak I, Antzelevitch C. Early repolarization syndrome: clinical characteristics and possible cellular and ionic mechanisms. J. Electrocardiol. 2000;33:299-309.
53. Chinushi M, Kuroe Y, Ito E, et al. Vasospastic angina accompanied by Brugada-type electrocardiographic abnormalities. J. Cardiovasc. Electrophysiol. 2001; 12: 108-111.
54. Nakamura W, Segawa K, Ito H et al. Class IC antiarrhyt-mic drugs: flecainide and pilsicainide, produce ST segment elevation simulating inferior myocardial ischemia. J. Cardiovasc. Electrophysiol. 1998;9:855-858.
55. Ortega-Carnicer J, Bertos-Polo J, Gutierrez-Tirado C. Aborted sudden death, transient Brugada pattern, and wide QRS dysrrhythmias after massive cocaine ingestion. J. Electrocardiol. 2001;34:345-349.
56. Kataoka H. Electrocardiographic patterns ofthe Brugada syndrome in 2 young patients with pectus excavatum. J. Electrocardiol. 2002; 35:169-171.
57. Kalla H, Yan GX, Marinchak R. Ventricular fibrillation in a patient with prominent J (Osborn) waves and ST segment elevation in the inferior electrocardiographic leads: a Brugada syndrome variant. J. Cardiovasc. Electrophysiol. 2000;11:95-1198.
58. Gonzalez Rebollo JM, Hernandez Madrid A et al. Recurrent ventricular fibrillation during a febrile illness in a patient with the Brugada syndrome. Rev. Esp. Cardiol. 2000;53:755-775.
59. Scheinman MM. Is the Brugada syndrome a distinct clinical entity. J. Cardiovasc. Electrophysiol. 1997;8:332-336.
60. Fischer S, Reinhold S, Kettner W. Kardiologische Abteilung der Medizinischen Klinik, Stadtisches Klinikum Magdeburg, Krankenhaus. Altstadt Med. Klin. 2001; 96:485-488.
61. Fujiki A, Usui M, Nagasawa H et al. ST segment elevation in the right precordial leads induced with class IC antiar-rhytmic drugs: insight into the mechanism of Brugada syndrome. J. Cardiovasc. Electrophysiol. 1999;10:214-218.
62. Shimizu W, Antzelevitch C, Suyama K et al. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J. Cardiovasc. Electrophysiol. 2000;11:1320-1329.
63. Brugada R, Brugada J,Antzelevitch C. et al. Sodium channel blockers identify risk for sudden death in-patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000;101:510-515.
64. Brugada R. Use of intravenous antiarrhythmics to identify concealed Brugada syndrome. Curr. Control Trials Cardiovasc. Med. 2000;1:45-47.
65. Brugada J, Brugada P, Brugada R. Ajmaline unmasks right bundle branch block-like and ST segment elevation in V1-V3 in-patients with idiopathic ventricular fibrillation. Pacing Clin. Electrophysiol. 1996; 19: 599 (Abstract).
66. Nishizaki M, Sakurada H, Ashikaga T et al. Effects of glucose-induced insulin secretion on ST segment elevation in the Brugada syndrome. J. Cardiovasc. Electrophysiol. 2003; 14:243-249.
67. Nogami A, Nakao M, Kubota S et al. Enhancement of J-ST-segment elevation by the glucose and insulin test in Brugada syndrome. Pacing Clin. Electrophysiol. 2003;26:332-337.
68. Shimizu W, Kamakura S. Catecholamines in children with congenital long QT syndrome and Brugada syndrome. J. Electrocardiol. 2001; 34:173-175.
69. Asenjo R, Madariaga R, Morris R et al. Sudden death due to recuperated ventricular fibrillation: Brugada syndrome. Rev. Med. Chil. 1998;126:814-821.
70. Tanaka H, Kinoshita O, Uchikawa S et al. Successful prevention of recurrent ventricular fibrillation by intravenous isoproterenol in a patient with Brugada syndrome. Pacing Clin. Electrophysiol. 2001;24:1293-1294.
71. Ayerza MR, de Zutter M, Goethals M, Wellens F, Geelen P, Brugada P. Heart transplantation as last resort against Brugada syndrome. J. Cardiovasc. Electrophysiol. 2002; 13:943-944.
72. Chalvidan T, Deharo JC, Dieuzaide P et al. Near fatal electrical storm in a patient equipped with an implantable cardioverter defibrillator for Brugada syndrome. Pacing Clin. Electrophysiol. 2000; 23:410-412.
73. Araú jo N, Godinho F, Maciel W et al. Pesquisa de Porta-dores Assintomáticos da Síndrome de Brugada Através do Teste da Ajmalina e Dobutamina. LIV Congresso Brasileiro de Cardiologia Tema Livre 084 Hospital Uni-versitário Clementino Fraga Filho UFRJ; Clínica São Vicente Rio de Janeiro-RJ Brasil.
74. Bjerregaard P, Gussak I, Antzelevitch C. The enigmatic ECG of the Brugada syndrome. Letter to the Editor. J. Cardiovasc. Electrophysiol. 1998;9:109-111.
75. Kakishita M, Kurita T, Matsuo K et al. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy. J.Am. Coll. Cardiol. 2000; 36:1646-1653.
76. Sastry BK, Narasimhan C, Soma Raju B. Brugada syndrome with monomorphic ventricular tachycardia in a one-year-old child. Indian Heart J. 2001;53:203-205.
77. Boersma LV, Jaarsma W, Jessurun ER, Van Hemel NH, Wever EF. Brugada syndrome: a case report of monomor-phic ventricular tachycardia. Pacing Clin. Electrophysiol. 2001; 24:112-115.
78. Ogawa M. Sustained monomorphic ventricular tachycardia originating from right ventricular outflow tract in Brugada syndrome. Virtual Symposium about the Brugada syndrome: ten years of history: 1992/2002) www.simposio-brugada.com.ar
79. Pinar Bermudez E, Garcia-Alberola A, Martinez Sanchez J, et al.Spontaneous sustained monomorphic ventricular tachycardia after administration ofajmaline in a patient with Brugada syndrome. Pacing Clin. Electrophysial 2000; 23:407-409.
80. Shimada M, Miyazaki T, Miyoshi S et al. Sustained monomorphic ventricular tachycardia in a patient with Brugada syndrome. Jpn. Circ. J. 1996;60:364-370.
81. Ogawa M, Kumagai K, Saku K. Spontaneous right ventricular outflow tract tachycardia in a patient with Brugada syndrome. J. Cardiovasc. Electrophysiol. 2001;12:838-840.
82. Martinez Sanchez J, Garcia Alberola A, Jose Sanchez Munoz J et al. Concurrent long QT and Brugada syndrome in a single patient. Rev. Esp. Cardiol. 2001;54:645-648.
83. Maarten P, van den Berg MD, Arthur AM. et al. Possible bradycardic mode of death and successful pacemaker treatment in a large family with features oflong QT syndrome Type 3 and Brugada syndrome. J. Cardiovasc. Electrophysiol. 2001;12:630-636.
84. Pastore CA et al. Diretrizes do ECG de repouso. Diretriz Normatização da interpretação do eletrocardio-grama de repouso. Arq. Bras. Cardiol. 2003; 80 supl I: 1-17.
85. Pastore CA, Moffa PJ, Tobias MO et al Bloqueios divi-sionais do ramo direito e áreas eletricamente inativas. Diagnóstico diferencial eletro-vetorcardiográfico. Arq. Bras. Cardiol. 1985; 45:309-317.
86. Pérez Riera AR. 'Right end conduction delay (RECD). Electorcardiographic criteria: proposal for classification and clinical significance.' Presented at the XLIX Congress of the Brazilian Society of Cardiology. Belo Horizonte-MG (August/1993).
87. Guevara-Valdivia ME, Iturralde Torres P, de Micheli A et al. Exercise test unmask apparent right bundle branch and ST segment elevation in the Brugada syndrome. Arch. Cardiol. Mex. 2001; 71:66-72.
88. Lee KL, Lau CP, Tse HF et al. Prevention of ventricular fibrillation by pacing in a man with Brugada syndrome. J. Cardiovasc. Electrophysiol. 2000; 1 : 935-937.
89. Miyazaki T, Mitamura H, Miyoshi S et al. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J. Am. Co//. Cardiol. 1996; 27:1061-1070.
90. Zipes DP. Genesis of cardiac arrhytmias electrophysiological considerations.In: Braunwald E. Heart Disease. Philadelphia:W.B.Saunders, 1997.
91. Eckardt L, Bruns HJ, Paul M et al. Body surface area of ST elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome. J. Cardiovasc. Electrophysiol. 2002;13:742-749.
92. Simsom MB, MacFarlane PW. In: Comprehensive Electrocardiology. Theory and Practice in Heath and Disease, Vol. 2. The Signal-Averaged Electrocardiogram. Chapter 33, 1204. Pergamon Press, 1989.
93. Buckingham TA, Thessen CC, Stevens LL et al. Effect of conduction defects on the signal-averaged electrocardiographic determination of late potentials. Am. J. Cardiol. 1988; 61:1265-1271.
94. Lepesckin E, Surawicz B. The measurement of the Q-T interval of the electrocardiogram. Circulation 1952;6:378-388.
95. Fei L, Statters DJ, Camm AJ. QT-interval dispersion on 12-lead electrocardiogram in normal subjects: its reproducibility and relation to the T wave. Am. Heart J. 1994; 127:1654-1655.
96. Schulze-Bahr E, Zoelch KA, Eckardt L, Haverkamp W, Breithardt G, Borggrefe M. Electrical alternans in long QT syndrome resembling a Brugada syndrome pattern. Pacing Clin. Electrophysiol. 2003;26:2033-2035.
97. Hering HE. Experientell studien na saugetieren uber das elektrocardogramm. Exp. Med. 1909;7:363.
98. Taussig HB. Electrograms taken from isolated strips of mammalian ventricle cardiac muscle. Buü.Johns Hopkins Hosp. 1928;43:81.
99. Fisch C, Edmands RE. Greenpan K. T wave alternans: Na association with abrupt rate change. Am. Heart J. 1971;81:817.
100. Navarro-Lopez F, Cinca J, Sanz G et al. Isolated T wave al-ternans elicited by hypocalcemia in dogs.J.Electrocardiol. 1978; 11:103-108.
101. Hiejima K, Sano T. Electrical alternans of TU wave in Romano-Ward syndrome. Br. Heart J. 1976; 38:767-770.
102. Schwartz PJ, Malliani A. Electrical alternations of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the QT long syndrome. Am. Heart J. 1975; 89:45-50.
103. Zareba W, Modd SJ, Le Cessie S et al. T-wave alternans in idiopathic long QT syndrome. J. Am. Coll. Cardiol. 1994;23:1541-1546.
104. Mirvis DM. Evaluation of normal variation in ST segment patterns by body surface isopotential mapping:S-T segment elevation in absence ofheart disease. Am. J. Cardiol. 1982; 50:122-128.
105. Fontaine G, Aouate P, Fontaliran F. Repolarization and the genesis of cardiac arrhythmias: role of body surface mapping [editorial comment]. Circulation 1997;95:2600-2602.
106. Hismatsu K, Kusano KF, Morita H et al. ST elevation characteristics in asymptomatic patients with Brugada ECG evaluated by body surface mapping: comparison with symptomatic Brugada syndrome. Circulation 2000;102:584.
107. Izumida N, Asano Y, Doi S et al. Changes in body surface maps by isoproterenol and Na channel blocker in patients with Brugada syndrome. Circulation 2000;102:583.
108. Bruns HJ, Eckardt L, Vahlhaus C et al. Body surface potential mapping in patients with Brugada syndrome: right precordial ST segment variations and reverse changes in left precordial leads. Cardiovasc. Res. 2002;54:58-66.